Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk
Alkermes plc (Nasdaq: ALKS) today announced that it has entered into a definitive agreement to sell its development and manufacturing facility in Athlone, Ireland to Novo Nordisk, a leading global healthcare company. Under the terms of the agreement, upon the closing of the transaction,…
Fluent BioSciences Awarded NIH SBIR Grant to Revolutionize Single Cell Analysis
Fluent BioSciences, a cutting edge life sciences company leading the charge in revolutionizing single cell analysis through simple, cost-effective, and highly scalable single-cell RNA sequencing solutions is thrilled to announce the award of an NIH Small Business Innovation Research (SBIR)…
